Literature DB >> 28627366

PQBP1, an intrinsically disordered/denatured protein at the crossroad of intellectual disability and neurodegenerative diseases.

Hitoshi Okazawa1.   

Abstract

PQBP1 (polyglutamine binding protein-1) is the earliest identified molecule among the group of disease-related intrinsically disordered/denatured proteins. PQBP1 interacts with splicing-related factors via the disordered/denatured domain and regulates post-transcriptional gene expression. The mutations cause intellectual disability due to decreased dendritic spines and abnormal expression of synapse molecules in neurons, and microcephaly due to elongated cell cycle time and abnormal expression of cell cycle proteins in neural stem progenitor cells. Meanwhile, PQBP1 interacts with polyglutamine tract sequences translated from CAG triplet disease genes via their disordered/denatured structures. The second hit on PQBP1 by such neurodegenerative disease proteins is supposed to similarly impair synapse functions in neuron and proliferation of stem cells. The alteration of gene expression profile and consequently induced phenotypes of neuron and stem cells via secondary impairment of the intrinsically disordered/denatured protein PQBP1, which are similar to developmental disorders by PQBP1 gene mutations, could be a part of the main pathologies shared by multiple neurodegenerative diseases.
Copyright © 2017 The Author. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Intellectual disability; Intrinsically disordered/denatured protein; Low complexity protein; Neurodegenerative disease; PQBP1; RNA splicing; Transcription

Mesh:

Substances:

Year:  2017        PMID: 28627366     DOI: 10.1016/j.neuint.2017.06.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

1.  Renpenning Syndrome in a Turkish Patient: de novo Variant c.607C>T in PACS1 and Hypogammaglobulinemia Phenotype.

Authors:  Fatma Kurt Colak; Nilnur Eyerci; Caner Aytekin; Ayse S Eksioglu
Journal:  Mol Syndromol       Date:  2020-04-17

2.  Heterozygous loss of WBP11 function causes multiple congenital defects in humans and mice.

Authors:  Ella M M A Martin; Annabelle Enriquez; Duncan B Sparrow; David T Humphreys; Aideen M McInerney-Leo; Paul J Leo; Emma L Duncan; Kavitha R Iyer; Joelene A Greasby; Eddie Ip; Eleni Giannoulatou; Delicia Sheng; Elizabeth Wohler; Clémantine Dimartino; Jeanne Amiel; Yline Capri; Daphné Lehalle; Adi Mory; Yael Wilnai; Yael Lebenthal; Ali G Gharavi; Grażyna G Krzemień; Monika Miklaszewska; Robert D Steiner; Cathy Raggio; Robert Blank; Hagit Baris Feldman; Hila Milo Rasouly; Nara L M Sobreira; Rebekah Jobling; Christopher T Gordon; Philip F Giampietro; Sally L Dunwoodie; Gavin Chapman
Journal:  Hum Mol Genet       Date:  2020-12-04       Impact factor: 6.150

3.  DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5.

Authors:  Naohide Kondo; Genki Tohnai; Kentaro Sahashi; Madoka Iida; Mayumi Kataoka; Hideaki Nakatsuji; Yutaka Tsutsumi; Atsushi Hashizume; Hiroaki Adachi; Haruki Koike; Keiko Shinjo; Yutaka Kondo; Gen Sobue; Masahisa Katsuno
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 12.137

4.  A genome-wide methylation study reveals X chromosome and childhood trauma methylation alterations associated with borderline personality disorder.

Authors:  María J Arranz; Cristina Gallego-Fabrega; Ana Martín-Blanco; Joaquim Soler; Matilde Elices; Elisabet Dominguez-Clavé; Juliana Salazar; Daniel Vega; Laia Briones-Buixassa; Juan Carlos Pascual
Journal:  Transl Psychiatry       Date:  2021-01-05       Impact factor: 6.222

5.  Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation.

Authors:  Meihua Jin; Hiroki Shiwaku; Hikari Tanaka; Takayuki Obita; Sakurako Ohuchi; Yuki Yoshioka; Xiaocen Jin; Kanoh Kondo; Kyota Fujita; Hidenori Homma; Kazuyuki Nakajima; Mineyuki Mizuguchi; Hitoshi Okazawa
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

Review 6.  Sensor Sensibility-HIV-1 and the Innate Immune Response.

Authors:  Xin Yin; Simon Langer; Zeli Zhang; Kristina M Herbert; Sunnie Yoh; Renate König; Sumit K Chanda
Journal:  Cells       Date:  2020-01-20       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.